Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.
Arylamine N-acetyltransferase (NAT) acetylates the front-line anti-tuberculosis drug isoniazid (INH) and has been identified in Mycobacterium tuberculosis. A naturally occurring single nucleotide polymorphism (SNP) was recently found in the NAT gene in clinical isolates of M. tuberculosis. The nucle...
Autors principals: | Kawamura, A, Sandy, J, Upton, A, Noble, M, Sim, E |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2003
|
Ítems similars
-
Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis.
per: Fullam, E, et al.
Publicat: (2009) -
Protein-ligand interactions of arylamine N-acetyltransferase from Mycobacterium smegmatis
per: Brooke, E
Publicat: (2003) -
The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
per: Sandy, J, et al.
Publicat: (2002) -
Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site.
per: Abuhammad, A, et al.
Publicat: (2010) -
Structure and mechanism of arylamine N-acetyltransferases.
per: Westwood, I, et al.
Publicat: (2006)